Evotec SE (ETR:EVT)
6.58
-0.30 (-4.36%)
Oct 17, 2025, 5:44 PM CET
Evotec SE Revenue
Evotec SE had revenue of 171.24 million EUR in the quarter ending June 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 777.33 million, down -1.41% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97 million with 1.99% growth.
Revenue (ttm)
777.33M
Revenue Growth
-1.41%
P/S Ratio
1.50
Revenue / Employee
163.34K
Employees
4,740
Market Cap
1.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bayer Aktiengesellschaft | 46.17B |
Siemens Healthineers AG | 23.38B |
Fresenius SE & Co. KGaA | 22.28B |
Merck KGaA | 21.22B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.52B |
Redcare Pharmacy NV | 2.68B |
Fielmann Group AG | 2.40B |
Evotec SE News
- 4 weeks ago - EQS-DD: Evotec SE: Paul Hitchin, buy - Wallstreet:Online
- 5 weeks ago - EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - EQS-DD: Evotec SE: Dr. Christian Wojczewski, buy - Wallstreet:Online
- 2 months ago - Evotec SE (EVO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evotec SE 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Evotec SE reports 1H results - Seeking Alpha
- 2 months ago - Earnings Scheduled For August 13, 2025 - Benzinga